First Trust IPOX Europe Equity Opps ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
First Trust IPOX Europe Equity Opportunities ETF FPXE
Morningstar’s Analysis FPXE
Will FPXE outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 52.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Technoprobe SpA | 7.04 | 330,363 | Technology |
Roche Holding AG Ordinary Shares new | 6.96 | 326,633 | Healthcare |
Bawag Group AG Ordinary Shares | 6.44 | 302,060 | Financial Services |
Swedish Orphan Biovitrum AB | 6.14 | 288,370 | Healthcare |
Nordnet AB (publ) Ordinary Shares | 5.81 | 272,829 | Financial Services |
Ascendis Pharma AS | 5.38 | 252,530 | Healthcare |
ARM Holdings PLC ADR | 4.77 | 223,811 | Technology |
Lottomatica Group SpA | 4.75 | 222,919 | Consumer Cyclical |
Andritz AG | 3.05 | 142,986 | Industrials |
Rio Tinto PLC Ordinary Shares | 2.45 | 115,118 | Basic Materials |